[Validation of using disqualification from long-term care insurance registry as a proxy of death].


Journal

[Nihon koshu eisei zasshi] Japanese journal of public health
ISSN: 0546-1766
Titre abrégé: Nihon Koshu Eisei Zasshi
Pays: Japan
ID NLM: 19130150R

Informations de publication

Date de publication:
04 Aug 2022
Historique:
pubmed: 12 5 2022
medline: 6 8 2022
entrez: 11 5 2022
Statut: ppublish

Résumé

Objectives The national database for long-term care insurance (LTCI) of Japan (Kaigo DB) enables researchers to access comprehensive data from its LTCI registry, eligibility assessment records, claims for service usage, and information about service providers. However, studies regarding the death or mortality of beneficiaries cannot be conducted because Kaigo DB does not contain death records, and researchers are not allowed to link Kaigo DB to other databases, such as national death records. Therefore, we aimed to assess the validity of using an insurer's disqualification from an LTCI beneficiary as a proxy of death.Methods We used 510,751,798 monthly beneficiary records between April 2007 and March 2017 from the LTCI registry, while excluding data for ineligible persons for LTCI benefit or those younger than 65 years. We identified insurer cases disqualified from LTCI beneficiaries and linked them to national death records using deterministic linkage methods by dates of birth and death, sex, and residence. We considered the cases as positive if they were disqualified and their record was linked to a death. We used sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) as validity indices.Results We identified 5,986,991 (1.17%) disqualified and 5,295,961 death cases. Sensitivity, specificity, PPV, and NPV of disqualification for death were 100%, 99.86%, 88.46%, and 100%, respectively. After stratification, PPV of disqualification was between 85% and 88% before 2012, 91% after 2012, 91.9% in men, and 85.9% in women. PPV increased with age (65-69 years: 80.6%, 70-74 years: 86.7%, 75-79 years: 86.4%, 80-84 years: 86.7%, 85-89 years: 88.0%, 90-94 years: 90.6%, and 95+ years: 93.4%) and level of care needed (support level: 72.2%, care level (CL) 1: 79.7%, CL2: 85.9%, CL3: 89.3%, CL4: 92.3%, and CL5: 94.0%).Conclusions Disqualification from the LTCI registry is an inappropriate measure to estimate mortality accurately because it has a 10% false-positive rate. However, it appears sufficiently valid to use disqualification as a proxy outcome of death, although the main effect or confounding of a possible predictor of death could be slightly underestimated.

Identifiants

pubmed: 35545514
doi: 10.11236/jph.21-121
doi:

Types de publication

Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

617-624

Auteurs

Mikiya Sato (M)

Department of Health Services Research, Faculty of Medicine, University of Tsukuba.
Human Resources Group, Sumitomo Heavy Industries, Ltd.

Tomoko Ito (T)

Department of Health Services Research, Faculty of Medicine, University of Tsukuba.
Health Services Research and Development Center, University of Tsukuba.

Yuta Taniguchi (Y)

Graduate School of Comprehensive Human Sciences, University of Tsukuba.

Chihiro Omori (C)

Graduate School of Comprehensive Human Sciences, University of Tsukuba.

Xueying Jin (X)

Department of Health Services Research, Faculty of Medicine, University of Tsukuba.
Health Services Research and Development Center, University of Tsukuba.

Taeko Watanabe (T)

Department of Health Services Research, Faculty of Medicine, University of Tsukuba.
Health Services Research and Development Center, University of Tsukuba.

Hideto Takahashi (H)

National Institute of Public Health.

Haruko Noguchi (H)

Faculty of Political Science and Economics, Waseda University.

Nanako Tamiya (N)

Department of Health Services Research, Faculty of Medicine, University of Tsukuba.
Health Services Research and Development Center, University of Tsukuba.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH